These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15642454)

  • 41. Clozapine replacement by quetiapine for the treatment of drug-induced psychosis in Parkinson's disease.
    Fernandez HH; Lannon MC; Friedman JH; Abbott BP
    Mov Disord; 2000 May; 15(3):579-81. PubMed ID: 10830427
    [No Abstract]   [Full Text] [Related]  

  • 42. Management of aggression, agitation, and psychosis in dementia: focus on atypical antipsychotics.
    Aupperle P
    Am J Alzheimers Dis Other Demen; 2006; 21(2):101-8. PubMed ID: 16634465
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ventricular ectopics during crossover of atypical antipsychotics.
    O'Shea M; Sazhin V; Collins A
    Aust N Z J Psychiatry; 2003 Dec; 37(6):773-4. PubMed ID: 14636396
    [No Abstract]   [Full Text] [Related]  

  • 44. Systematic Literature Review of Quetiapine for the Treatment of Psychosis in Patients With Parkinsonism.
    Chen JJ; Hua H; Massihi L; Portillo I; Alipour A; Ondo W; Dashtipour K
    J Neuropsychiatry Clin Neurosci; 2019; 31(3):188-195. PubMed ID: 30848989
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A single-blind, randomized trial comparing quetiapine and haloperidol in the treatment of tardive dyskinesia.
    Emsley R; Turner HJ; Schronen J; Botha K; Smit R; Oosthuizen PP
    J Clin Psychiatry; 2004 May; 65(5):696-701. PubMed ID: 15163258
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison.
    Keefe RS; Sweeney JA; Gu H; Hamer RM; Perkins DO; McEvoy JP; Lieberman JA
    Am J Psychiatry; 2007 Jul; 164(7):1061-71. PubMed ID: 17606658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical predictors of acute response with quetiapine in psychotic mood disorders.
    Zarate CA; Rothschild A; Fletcher KE; Madrid A; Zapatel J
    J Clin Psychiatry; 2000 Mar; 61(3):185-9. PubMed ID: 10817103
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quetiapine in postpartum psychosis.
    Gobbi G
    J Clin Psychopharmacol; 2014 Dec; 34(6):744-5. PubMed ID: 24943395
    [No Abstract]   [Full Text] [Related]  

  • 49. Olanzapine versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Duggan L; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Mar; (3):CD006654. PubMed ID: 20238348
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
    Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S
    Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacology of antipsychotics in the elderly: a focus on atypicals.
    Finkel S
    J Am Geriatr Soc; 2004 Dec; 52(12 Suppl):S258-65. PubMed ID: 15541166
    [No Abstract]   [Full Text] [Related]  

  • 52. Tardive dyskinesia rates with atypical antipsychotics in older adults.
    Jeste DV
    J Clin Psychiatry; 2004; 65 Suppl 9():21-4. PubMed ID: 15189108
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) study.
    Mullen J; Jibson MD; Sweitzer D
    Clin Ther; 2001 Nov; 23(11):1839-54. PubMed ID: 11768836
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quetiapine resolves psychotic depression in an adolescent boy.
    Padla D
    J Child Adolesc Psychopharmacol; 2001; 11(2):207-8. PubMed ID: 11436964
    [No Abstract]   [Full Text] [Related]  

  • 55. Quetiapine and QTc issues: a case report.
    Gupta S; Nienhaus K; Shah SA
    J Clin Psychiatry; 2003 May; 64(5):612-3. PubMed ID: 12755671
    [No Abstract]   [Full Text] [Related]  

  • 56. Quetiapine for Psychosis in Parkinson Disease and Neurodegenerative Parkinsonian Disorders: A Systematic Review.
    Desmarais P; Massoud F; Filion J; Nguyen QD; Bajsarowicz P
    J Geriatr Psychiatry Neurol; 2016 Jul; 29(4):227-36. PubMed ID: 27056066
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Atypical antipsychotic drugs in the treatment of Parkinson's disease.
    Friedman JH
    J Pharm Pract; 2011 Dec; 24(6):534-40. PubMed ID: 22095576
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Datapoints: The ups and downs of dosing second-generation antipsychotics.
    Citrome L; Jaffe A; Levine J
    Psychiatr Serv; 2007 Jan; 58(1):11. PubMed ID: 17215406
    [No Abstract]   [Full Text] [Related]  

  • 59. Therapeutic tolerance and rebound psychosis during quetiapine maintenance monotherapy in patients with schizophrenia and schizoaffective disorder.
    Margolese HC; Chouinard G; Beauclair L; Bélanger MC
    J Clin Psychopharmacol; 2002 Aug; 22(4):347-52. PubMed ID: 12172332
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Quetiapine and ziprasidone in the treatment of the psychotic disorders in Parkinson's disease].
    López del Val LJ; Santos S
    Rev Neurol; 2004 Oct 1-15; 39(7):661-7. PubMed ID: 15490355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.